Michael S. Baker Jr.

PhD candidate, Department of Clinical Neurosciences, University of Cambridge

My research focuses on multimodality monitoring in neurocritical care, particularly identifying and treating metabolic crises after acute brain injury.

Cambridge Neuroscience ResearchGate Google Scholar ORCID
mail@michaelsbakerjr.com

In Progress

  1. The microdialysis-derived lactate–pyruvate gradient indicates anaerobic activity after brain injury Accepted at Journal of Cerebral Blood Flow & Metabolism, 20 August 2026. Analysis code available on GitHub.

Publications

  1. A meta-epidemiologic analysis of differences in treatment-effect estimates according to outcome scale (GOS vs. GOSE) in moderate-to-severe traumatic brain injury trials Neurocritical Care, published online 21 August 2026.
  2. Consensus statement from the 2025 Delphi panel on cerebral microdialysis in critical care Critical Care, 2026.
  3. Defining metabolic abnormalities in acute human traumatic brain injury with cerebral microdialysis and multimodality monitoring PLoS One, 2025.
  4. Multimodality Monitoring for the Management of Severe Traumatic Brain Injury Neurosurgery Clinics of North America, 2025.